Page last updated: 2024-08-24

oseltamivir and Kidney Failure, Chronic

oseltamivir has been researched along with Kidney Failure, Chronic in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (50.00)	29.6817
2010's	5 (41.67)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B	1
Giraudon, M; Kamal, MA; Kirkpatrick, CM; Morcos, PN; Patel, K; Rayner, CR; Robson, R	1
Clinch, B; Gibiansky, L; Kamal, MA; Lien, KY; Rayner, CR; Robson, R; Subramoney, V	1
Bueti, J; Komenda, P; Reslerova, M; Rigatto, C; Sood, MM; Wiebe, C	1
de Almeida, M; Jurawan, R; Smith, A; Weilert, F	1
Akalin, E; Chapochnick-Friedmann, J; Lu, A; Marfo, K	1
Li, H; Wang, SX	1
Choo, D; Chowdhury, S; Hossain, M; Liew, P; Tan, J	1
Godara, SM; Goplani, KR; Kute, V; Shah, PR; Trivedii, HL; Vanikar, AV	1
Myers, JW	1
Brewster, M; Buttimore, A; Lynn, K; Robson, R; Ward, P	1
Deray, G; Izzedine, H; Janus, N; Karie, S; Launay-Vacher, V	1

Reviews

1 review(s) available for oseltamivir and Kidney Failure, Chronic

Article	Year
Influenza therapy. Southern medical journal, 2003, Volume: 96, Issue:8 Topics: Acetamides; Adult; Age Factors; Amantadine; Antiviral Agents; Child; Cost-Benefit Analysis; Creatine; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Metabolic Clearance Rate; Oseltamivir; Patient Selection; Primary Prevention; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir	2003

Article

Year

Influenza therapy.

Southern medical journal, 2003, Volume: 96, Issue:8

Topics: Acetamides; Adult; Age Factors; Amantadine; Antiviral Agents; Child; Cost-Benefit Analysis; Creatine; Disease Outbreaks; Drug Resistance, Viral; Guanidines; Humans; Influenza A virus; Influenza, Human; Kidney Failure, Chronic; Metabolic Clearance Rate; Oseltamivir; Patient Selection; Primary Prevention; Pyrans; Sialic Acids; Treatment Outcome; Zanamivir

2003

Trials

2 trial(s) available for oseltamivir and Kidney Failure, Chronic

Article	Year
Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis. British journal of clinical pharmacology, 2015, Volume: 79, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Oseltamivir; Peritoneal Dialysis; Prospective Studies	2015
The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:9 Topics: Acetamides; Administration, Oral; Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Follow-Up Studies; Humans; Influenza, Human; Kidney Failure, Chronic; Male; Middle Aged; Neuraminidase; Oseltamivir; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Treatment Outcome	2006

Article

Year

Pharmacokinetics and safety of oseltamivir in patients with end-stage renal disease treated with automated peritoneal dialysis.

British journal of clinical pharmacology, 2015, Volume: 79, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Monte Carlo Method; Oseltamivir; Peritoneal Dialysis; Prospective Studies

2015

The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:9

Topics: Acetamides; Administration, Oral; Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Viral; Female; Follow-Up Studies; Humans; Influenza, Human; Kidney Failure, Chronic; Male; Middle Aged; Neuraminidase; Oseltamivir; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis; Treatment Outcome

2006

Other Studies

9 other study(ies) available for oseltamivir and Kidney Failure, Chronic

Article	Year
Case report: A kidney transplant patient with mild COVID-19. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:4 Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus	2020
Investigating clinically adequate concentrations of oseltamivir carboxylate in end-stage renal disease patients undergoing hemodialysis using a population pharmacokinetic approach. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:11 Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Models, Theoretical; Oseltamivir; Renal Dialysis; Young Adult	2015
Atypical clinical presentation of H1N1 influenza in a dialysis patient. Lancet (London, England), 2009, Oct-10, Volume: 374, Issue:9697 Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Dyspnea; Emergency Treatment; Glomerulosclerosis, Focal Segmental; Hemoptysis; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Male; Oseltamivir; Renal Dialysis	2009
Swine H1N1 influenza in a post liver transplant patient. The New Zealand medical journal, 2009, Oct-09, Volume: 122, Issue:1304 Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Disease Outbreaks; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Intensive Care Units; Kidney Failure, Chronic; Liver Cirrhosis; Liver Transplantation; Opportunistic Infections; Oseltamivir; Postoperative Complications; Prednisone; Respiratory Insufficiency; Tacrolimus	2009
Postexposure prophylaxis of H1N1 with oseltamivir in a newly transplanted kidney recipient receiving intense immunosuppressive therapy. Transplantation proceedings, 2009, Volume: 41, Issue:10 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antiviral Agents; Cesarean Section; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Medical History Taking; Oseltamivir; Pregnancy; Renal Dialysis; Risk Factors; Rituximab; Siblings; Treatment Outcome	2009
Clinical features of 2009 pandemic influenza A (H1N1) virus infection in chronic hemodialysis patients. Blood purification, 2010, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; China; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Male; Middle Aged; Oseltamivir; Pandemics; Renal Dialysis; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Virus Shedding	2010
Side effects of oseltamivir in end-stage renal failure patients. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:7 Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Antiviral Agents; Brunei; Cross-Sectional Studies; Dizziness; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Nausea; Oseltamivir; Patient Compliance; Prognosis; Renal Replacement Therapy; Risk Factors; Young Adult	2011
Post-exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient--safe and effective without any immunosuppresive drug interaction. The Journal of the Association of Physicians of India, 2011, Volume: 59 Topics: Adult; Antiviral Agents; Drug Interactions; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Influenza A Virus, H1N1 Subtype; Influenza, Human; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Oseltamivir; Postoperative Complications; Pregnancy; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Homologous; Treatment Outcome	2011
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:12 Topics: Antiviral Agents; Enzyme Inhibitors; Humans; Influenza, Human; Kidney Failure, Chronic; Oseltamivir; Zanamivir	2006